These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9210625

  • 1. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
    Oberti F, Pilette C, Rifflet H, Maïga MY, Moreau A, Gallois Y, Girault A, le Bouil A, Le Jeune JJ, Saumet JL, Feldmann G, Calès P.
    J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
    [Abstract] [Full Text] [Related]

  • 2. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
    Oberti F, Rifflet H, Maïga MY, Pilette C, Gallois Y, Douay O, Le Jeune JJ, Saumet JL, Calès P.
    J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J.
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension.
    Burns RC, Wu Y, Sitzmann JV.
    Surgery; 1995 May; 117(5):488-93. PubMed ID: 7740418
    [Abstract] [Full Text] [Related]

  • 13. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
    Wong J, Zhang Y, Lee SS.
    J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
    [Abstract] [Full Text] [Related]

  • 14. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats.
    Fort J, Oberti F, Pilette C, Veal N, Gallois Y, Douay O, Rousselet MC, Rosenbaum J, Calès P.
    Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
    Hsu SJ, Wang SS, Huo TI, Lee FY, Huang HC, Chang CC, Hsin IF, Ho HL, Lin HC, Lee SD.
    J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI, Zipprich A, Fernandez-Mena C, Puerto M, Bosoi CR, Almagro J, Hollenbach M, Bañares J, Rodríguez-Sánchez B, Cercenado E, Clément MA, Rose CF, Bañares R, Vaquero J, Ripoll C.
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.